PRFDX
Price
$37.02
Change
+$0.15 (+0.41%)
Updated
Jul 3 closing price
Net Assets
16.63B
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PRFDX vs VVIAX

Header iconPRFDX vs VVIAX Comparison
Open Charts PRFDX vs VVIAXBanner chart's image
T. Rowe Price Equity Income
Price$37.02
Change+$0.15 (+0.41%)
VolumeN/A
Net Assets16.63B
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PRFDX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PRFDX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRFDX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. PRFDX (16.6B). VVIAX pays higher dividends than PRFDX: VVIAX (2.18) vs PRFDX (1.73). PRFDX was incepted earlier than VVIAX: PRFDX (40 years) vs VVIAX (25 years). PRFDX (0.67) is less costly to investors than VVIAX (0.05). PRFDX is a more actively managed with annual turnover of: 21.40 vs. VVIAX (9.00). PRFDX has a lower initial minimum investment than VVIAX: PRFDX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. PRFDX (4.80). VVIAX return over 5 years is better than : 80.13 vs. PRFDX (56.76).
PRFDXVVIAXPRFDX / VVIAX
Total Expense Ratio0.670.051,340%
Annual Report Gross Expense Ratio0.670.051,340%
Fund Existence40 years25 years-
Gain YTD7.7566.198125%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets16.6B189B9%
Annual Yield % from dividends1.732.1880%
Returns for 1 year4.8012.0340%
Returns for 3 years19.3535.1755%
Returns for 5 years56.7680.1371%
Returns for 10 years35.18115.6730%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.